Tirzepatide is a newer medication that activates both GLP-1 and GIP receptors, another gut hormone
INCONTINENCE One of our Associates, a Medical Doctor, gave Cellgevity to a patient who was unable to control her bowels or urine
doi: 10.3389/FENDO.2024.1431292 48 MollHFreyEGerberPGeidlBKaufmannMBraunJet al
5- other GLP-1 trials in Parkinsons have been statistically negative or the results unclear, 6- the study was conducted in only very early Parkinsons cases, 7- the data, if replicable, may not be generalizable to all GLP-1 agonist drugs or to all subtypes of Parkinsons, and 8- the drug Lixisenatide requires a DAILY injection
Here are some effective strategies to help manage constipation
Jolles JW, de Visser L, van den Bos R